ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
0.00%
Bitcoin
67,889.65
0.24%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Regencell Bioscience Holdings Ltd (RGC)

  7. Regencell Bioscience Holdings Ltd (RGC) News

RGC

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RGC
DateTimeSourceHeadlineSymbolCompany
01/02/20245:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/15/20235:09AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RGCRegencell Bioscience Holdings Ltd
10/27/20233:15PMEdgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:RGCRegencell Bioscience Holdings Ltd
06/15/20233:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
06/05/20235:07AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
03/17/20235:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
02/28/20238:16AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
01/04/20237:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/22/20226:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
10/31/20223:18PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:RGCRegencell Bioscience Holdings Ltd
09/12/20228:18AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
09/12/20228:15AMBusiness WireRegencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy TrialNASDAQ:RGCRegencell Bioscience Holdings Ltd
07/26/20227:34AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
06/07/202210:37AMValueWalkGame-Stop Or Game-On? RGC Has It All And Twice MoreNASDAQ:RGCRegencell Bioscience Holdings Ltd
06/02/20223:17PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
05/18/20227:05AMBusiness WireRegencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment PeriodNASDAQ:RGCRegencell Bioscience Holdings Ltd
05/18/20226:58AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
05/16/20227:56AMBusiness WireRegencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEONASDAQ:RGCRegencell Bioscience Holdings Ltd
05/16/20226:02AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
05/16/20226:00AMBusiness WireRegencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEONASDAQ:RGCRegencell Bioscience Holdings Ltd
05/16/20225:51AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
04/26/20227:08AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
04/04/20226:31AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/30/20213:06PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/15/20218:49AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/13/20217:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
11/17/20214:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
10/29/20217:32AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:RGCRegencell Bioscience Holdings Ltd
09/07/20213:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
09/01/20213:21PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
 Showing the most relevant articles for your search:NASDAQ:RGC

Your Recent History

NASDAQ
PMEC
Primech
LSE
0KAV
Arnoldo Mondadori Editore
BIT
F38922
Vontobel Financial Produ...
COIN
SOOMEUR
BIT
I08643
Intesa Sanpaolo
BIT
MTF
Mondo TV France
NASDAQ
FEXSPX
High Dividend Equity Por...
BIT
F11817
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved